Clinical trial
Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or…
NCT00004164 · Dana-Farber Cancer Institute, Other · Unknown status
Key facts
| NCT number | NCT00004164 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx |
| Official title | A Phase II Trial of Docetaxel, Cisplatin, 5-FU, and Leucovorin for Carcinoma of the Nasopharnyx |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Biological, Drug, Radiation |
| Interventions | filgrastim, cisplatin, docetaxel, fluorouracil, leucovorin calcium, radiation therapy |
| Start date | Aug 1, 1999 |
| First posted | Jul 19, 2004 |
| Last update posted | Feb 9, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: